# EUS-Endodrill vs. EUS-FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract

> **NCT02744651** · NA · TERMINATED · sponsor: **Region Skane** · enrollment: 4 (actual)

## Conditions studied

- Gastrointestinal Neoplasms

## Interventions

- **DEVICE:** EUS-FNA
- **DEVICE:** EUS-Endodrill biopsy

## Key facts

- **NCT ID:** NCT02744651
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-17
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Practical circumstances making it not possible to finish the study.
- **Last updated:** 2022-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02744651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02744651, "EUS-Endodrill vs. EUS-FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02744651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
